Treatment strategies for infective endocarditis

Bibliography

• Hoen B, Alla F, Selton-Suty C, Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002;288:75-81
   PubMed Web of Science ®Google Scholar
• Cabell CH, Jollis JG, Peterson GE, Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90-4
   PubMedGoogle Scholar
• Murdoch DR, Corey GR, Hoen B, Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009;169:463-73
   PubMed Web of Science ®Google Scholar
• Fowler VG, Scheld WM, Bayer AS. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases, 6th edition. Elsevier Churchill Livingstone, Philadelphia, PA; 2005. p. 975-1022
   Google Scholar
• Baddour LM, Wilson WR, Bayer AS, Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394-434
   PubMed Web of Science ®Google Scholar
• Tleyjeh IM, Abdel-Latif A, Rahbi H, A systematic review of population-based studies of infective endocarditis. Chest 2007;132:1025-35
   PubMed Web of Science ®Google Scholar
• Durante-Mangoni E, Bradley S, Selton-Suty C, Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med 2008;168:2095-103
   PubMedGoogle Scholar
• Hill EE, Herijgers P, Claus P, Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 2007;28:196-203
   PubMed Web of Science ®Google Scholar
• Dhawan VK. Infective endocarditis in elderly patients. Clin Infect Dis 2002;34:806-12
   PubMed Web of Science ®Google Scholar
• Benito N, Miro JM, de Lazzari E, Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 2009;150:586-94
   PubMed Web of Science ®Google Scholar
• Bouza E, Menasalvas A, Munoz P, Infective endocarditis–a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore) 2001;80:298-307
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345:1318-30
   PubMed Web of Science ®Google Scholar
• Millar BC, Prendergast BD, Moore JE. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother 2008;61:1-7
   PubMedGoogle Scholar
• Fowler VG Jr, Miro JM, Hoen B, Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005 22;293:3012-21
   Google Scholar
• Sanabria TJ, Alpert JS, Goldberg R, Increasing frequency of staphylococcal infective endocarditis. Experience at a university hospital, 1981 through 1988. Arch Intern Med 1990;150:1305-9
   Google Scholar
• Li JS, Sexton DJ, Mick N, Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8
   PubMed Web of Science ®Google Scholar
• Berlin JA, Abrutyn E, Strom BL, Assessing diagnostic criteria for active infective endocarditis. Am J Cardiol 1994;73:887-91
   Google Scholar
• Raoult D, Casalta JP, Richet H, Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 2005;43:5238-42
   PubMed Web of Science ®Google Scholar
• Hoen B, Selton-Suty C, Lacassin F, Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis 1995;20:501-6
   PubMed Web of Science ®Google Scholar
• Werner M, Andersson R, Olaison L, Hogevik H. A clinical study of culture-negative endocarditis. Medicine (Baltimore) 2003;82:263-73
   PubMed Web of Science ®Google Scholar
• Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 2001;14:177-207
   PubMed Web of Science ®Google Scholar
• Elliott TS, Foweraker J, Gould FK, Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2004;54:971-81
   PubMed Web of Science ®Google Scholar
• Habib G,Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009;30:2369-413
   PubMed Web of Science ®Google Scholar
• Hamburger M, Stein L. Streptococcus viridans subacute bacterial endocarditis; two week treatment schedule with penicillin. J Am Med Assoc 1952;149:542-5
   PubMedGoogle Scholar
• Durack DT, Beeson PB. Experimental bacterial endocarditis. II. Survival of a bacterium in endocardial vegetations. Br J Exp Pathol 1972;53:50-3
   PubMedGoogle Scholar
• Wilson WR, Karchmer AW, Dajani AS, Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 1995;274:1706-13
   PubMed Web of Science ®Google Scholar
• Korzeniowski OM, Kaye D. Endocarditis. In: Gorbach SL, Bartlett JG, Blacklow NR, editors. Infectious Diseases. 2nd edition. WB Saunders Co, Philadelphia, PA; 1998. p. 663-74
   Google Scholar
• Delahaye F, Goulet V, Lacassin F, Characteristics of infective endocarditis in France in 1991. A 1-year survey. Eur Heart J 1995;16:394-401
   PubMed Web of Science ®Google Scholar
• Aronin SI, Mukherjee SK, West JC, Cooney EL. Review of pneumococcal endocarditis in adults in the penicillin era. Clin Infect Dis 1998;26:165-71
   PubMed Web of Science ®Google Scholar
• Lefort A, Lortholary O, Casassus P, Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri: a multicenter study in France. Arch Intern Med 2002;162:2450-6
   PubMedGoogle Scholar
• Knoll B, Tleyjeh IM, Steckelberg JM, Infective endocarditis due to penicillin-resistant viridans group streptococci. Clin Infect Dis 2007;44:1585-92
   PubMedGoogle Scholar
• Senn L, Entenza JM, Greub G, Bloodstream and endovascular infections due to abiotrophia defectiva and granulicatella species. BMC Infect Dis 2006;6:9
   PubMed Web of Science ®Google Scholar
• Baddour LM. Infective endocarditis caused by beta-hemolytic streptococci. The Infectious Diseases Society of America's Emerging Infections Network. Clin Infect Dis 1998;26:66-71
   PubMed Web of Science ®Google Scholar
• Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000;342:710-21
   PubMed Web of Science ®Google Scholar
• Megran DW. Diagnosis and treatment of enterococcal endocarditis. Hosp Pract (Off Ed) 1993;28:41-4, 7-50
   Web of Science ®Google Scholar
• Fernandez Guerrero ML, Goyenechea A, Verdejo C, Enterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic factors with emphasis on hospital-acquired infections as a major determinant of outcome. Medicine (Baltimore) 2007;86:363-77
   PubMed Web of Science ®Google Scholar
• Stevens MP, Edmond MB. Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature. Clin Infect Dis 2005;41:1134-42
   PubMed Web of Science ®Google Scholar
• McDonald JR, Olaison L, Anderson DJ, Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database. Am J Med 2005;118:759-66
   PubMed Web of Science ®Google Scholar
• Murray BE. Beta-lactamase-producing enterococci. Antimicrob Agents Chemother 1992;36:2355-9
   PubMed Web of Science ®Google Scholar
• Fontana R, Canepari P, Lleo MM, Satta G. Mechanisms of resistance of enterococci to beta-lactam antibiotics. Eur J Clin Microbiol Infect Dis 1990;9:103-5
   Google Scholar
• Chou YY, Lin TY, Lin JC, Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between enterococcus faecium and enterococcus faecalis. J Microbiol Immunol Infect 2008;41:124-9
   PubMedGoogle Scholar
• Gold HS. Vancomycin-resistant enterococci: mechanisms and clinical observations. Clin Infect Dis 2001;33:210-9
   PubMed Web of Science ®Google Scholar
• Gavalda J, Len O, Miro JM, Brief communication: treatment of enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med 2007;146:574-9
   PubMedGoogle Scholar
• Gavalda J, Torres C, Tenorio C, Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother 1999;43:639-46
   PubMed Web of Science ®Google Scholar
• Mave V, Garcia-Diaz J, Islam T, Hasbun R. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid? J Antimicrob Chemother 2009;64:175-80
   PubMed Web of Science ®Google Scholar
• Fowler VG Jr, Boucher HW, Corey GR, Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006;355:653-65
   PubMed Web of Science ®Google Scholar
• Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant staphylococcus aureus endocarditis. Ann Intern Med 1991;115:674-80
   PubMed Web of Science ®Google Scholar
• Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 2007;28:273-9
   PubMed Web of Science ®Google Scholar
• Cosgrove SE, Sakoulas G, Perencevich EN, Comparison of mortality associated with methicillin-resistant and methicillin-susceptible staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53-9
   PubMed Web of Science ®Google Scholar
• Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med 1982;97:496-503
   PubMed Web of Science ®Google Scholar
• Wang G, Hindler JF, Ward KW, Bruckner DA. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol 2006;44:3883-6
   PubMed Web of Science ®Google Scholar
• Sakoulas G, Moise-Broder PA, Schentag J, Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004;42:2398-402
   PubMed Web of Science ®Google Scholar
• Hidayat LK, Hsu DI, Quist R, High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 2006;166:2138-44
   PubMed Web of Science ®Google Scholar
• Maclayton DO, Suda KJ, Coval KA, Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin Ther 2006;28:1208-16
   PubMed Web of Science ®Google Scholar
• Jones RN. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin Infect Dis 2006;42(Suppl 1):S13-24
   Google Scholar
• Lodise TP, Graves J, Evans A, Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008;52:3315-20
   PubMed Web of Science ®Google Scholar
• Rehm SJ, Boucher H, Levine D, Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates. J Antimicrob Chemother 2008;62:1413-21
   PubMed Web of Science ®Google Scholar
• Sakoulas G, Eliopoulos GM, Alder J, Eliopoulos CT. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003;47:1714-8
   PubMed Web of Science ®Google Scholar
• Hayden MK, Rezai K, Hayes RA, Development of Daptomycin resistance in vivo in methicillin-resistant staphylococcus aureus. J Clin Microbiol 2005;43:5285-7
   PubMed Web of Science ®Google Scholar
• Batard E, Jacqueline C, Boutoille D, Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study. Antimicrob Agents Chemother 2002;46:2174-8
   PubMed Web of Science ®Google Scholar
• Dailey CF, Dileto-Fang CL, Buchanan LV, Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant staphylococcus aureus. Antimicrob Agents Chemother 2001;45:2304-8
   PubMed Web of Science ®Google Scholar
• Ruiz ME, Guerrero IC, Tuazon CU. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid. Clin Infect Dis 2002;35:1018-20
   PubMed Web of Science ®Google Scholar
• Pistella E, Campanile F, Bongiorno D, Successful treatment of disseminated cerebritis complicating methicillin-resistant staphylococcus aureus endocarditis unresponsive to vancomycin therapy with linezolid. Scand J Infect Dis 2004;36:222-5
   PubMedGoogle Scholar
• Howden BP, Ward PB, Charles PG, Treatment outcomes for serious infections caused by methicillin-resistant staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 2004;38:521-8
   PubMed Web of Science ®Google Scholar
• Hiramatsu K, Aritaka N, Hanaki H, Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1670-3
   PubMed Web of Science ®Google Scholar
• Cha R, Brown WJ, Rybak MJ. Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 2003;47:3960-3
   PubMed Web of Science ®Google Scholar
• Chu VH, Cabell CH, Abrutyn E, Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2004;39:1527-30
   PubMed Web of Science ®Google Scholar
• Chu VH, Woods CW, Miro JM, Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 2008;46:232-42
   PubMed Web of Science ®Google Scholar
• Rupp ME. Coagulase-negative staphylococcal infections: an update regarding recognition and management. Curr Clin Top Infect Dis 1997;17:51-87
   PubMedGoogle Scholar
• Drinkovic D, Morris AJ, Pottumarthy S, Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis. J Antimicrob Chemother 2003;52:820-5
   PubMed Web of Science ®Google Scholar
• Karchmer AW, Archer GL, Dismukes WE. Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis. Rev Infect Dis 1983;5(Suppl 3):S543-8
   Google Scholar
• Archer GL, Johnston JL, Vazquez GJ, Haywood HB III. Efficacy of antibiotic combinations including rifampin against methicillin-resistant staphylococcus epidermidis: in vitro and in vivo studies. Rev Infect Dis 1983;5(Suppl 3):S538-42
   Google Scholar
• Chuard C, Herrmann M, Vaudaux P, Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother 1991;35:2611-6
   PubMed Web of Science ®Google Scholar
• Rouse MS, Wilcox RM, Henry NK, Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant staphylococcus epidermidis. Antimicrob Agents Chemother 1990;34:273-6
   PubMedGoogle Scholar
• Mohan SS, McDermott BP, Cunha BA. Methicillin-resistant staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin. Heart Lung 2005;34:69-71
   PubMed Web of Science ®Google Scholar
• Souli M, Pontikis K, Chryssouli Z, Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant staphylococcus aureus with linezolid. Eur J Clin Microbiol Infect Dis 2005;24:760-2
   PubMedGoogle Scholar
• Geraci JE WWSoie, III III. endocarditis, due to gram-negative bacteria. Mayo Clin Proc 1982;57:145-8
   Google Scholar
• Baron EJ, Scott JD, Tompkins LS. Prolonged incubation and extensive subculturing do not increase recovery of clinically significant microorganisms from standard automated blood cultures. Clin Infect Dis 2005;41:1677-80
   PubMed Web of Science ®Google Scholar
• Petti CA, Bhally HS, Weinstein MP, Utility of extended blood culture incubation for isolation of haemophilus, actinobacillus, cardiobacterium, eikenella, and kingella organisms: a retrospective multicenter evaluation. J Clin Microbiol 2006;44:257-9
   PubMed Web of Science ®Google Scholar
• Rolain JM, Brouqui P, Koehler JE, Recommendations for treatment of human infections caused by bartonella species. Antimicrob Agents Chemother 2004;48:1921-33
   PubMed Web of Science ®Google Scholar
• Raoult D, Fournier PE, Vandenesch F, Outcome and treatment of bartonella endocarditis. Arch Intern Med 2003;163:226-30
   PubMedGoogle Scholar
• Brouqui P, Dupont HT, Drancourt M, Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis. Arch Intern Med 1993;153:642-8
   PubMedGoogle Scholar
• Fenollar F, Fournier PE, Carrieri MP, Risks factors and prevention of Q fever endocarditis. Clin Infect Dis 2001;33:312-6
   PubMed Web of Science ®Google Scholar
• Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999;12:518-53
   PubMed Web of Science ®Google Scholar
• Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore) 2005;84:162-73
   PubMed Web of Science ®Google Scholar
• Raoult D, Houpikian P, Tissot Dupont H, Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med 1999;159:167-73
   PubMedGoogle Scholar
• Cohen PS MJ, Weinstein L. Infective endocarditis caused by, gram-negative bacteria: a review of the literature. Prog Cardiovasc Dis 1980;22:205-42
   Google Scholar
• Reyes M, Palutke, WA, Pseudomonas endocarditis in the Detroit Medical Center, 1969-1972. Medicine (Baltimore) 1973;52:173
   PubMed Web of Science ®Google Scholar
• Wieland M, Lederman MM, Kline-King C, Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literature. Medicine (Baltimore) 1986;65:180-9
   PubMedGoogle Scholar
• Fernandez-Guerrero ML. Zoonotic endocarditis. Infect Dis Clin North Am 1993;7:135-52
   PubMedGoogle Scholar
• Brook I. Infective endocarditis caused by anaerobic bacteria. Arch Cardiovasc Dis 2008;101:665-76
   PubMed Web of Science ®Google Scholar
• Felner JM, Dowell VR Jr. Anaerobic bacterial endocarditis. N Engl J Med 1970;283:1188-92
   PubMed Web of Science ®Google Scholar
• Ellis ME, Al-Abdely H, Sandridge A, Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 2001;32:50-62
   PubMed Web of Science ®Google Scholar
• Baddley JW, Benjamin DK Jr, Patel M, Candida infective endocarditis. Eur J Clin Microbiol Infect Dis 2008;27:519-29
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes D, Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-35
   PubMed Web of Science ®Google Scholar
• Bonow R, Carabello BA, Chatterjee K, ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 2006;48:e1
   Google Scholar
• Wilson W, Taubert KA, Gewitz M, Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-54
   PubMed Web of Science ®Google Scholar
• Gould FK, Elliott TS, Foweraker J, Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2006;57:1035-42
   PubMed Web of Science ®Google Scholar